Literature DB >> 28371472

Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis.

Su-Jie Jia1,2, Ke-Qin Gao2, Ming Zhao1.   

Abstract

Atherosclerosis is a chronic inflammatory disease. Recently, a growing body of evidence emphasizes that the monocyte and macrophage differentiation and activation are key processes in the development of atherosclerosis. However, the regulatory mechanism that manipulates the function of monocyte and macrophage is still unclear. Recent years, epigenetic mechanisms have received a wide attention and bring us a new field of vision. More and more evidence shows that epigenetics weighs heavily in atherosclerosis by regulating the function and differentiation states of monocyte and macrophage. In this review, we illuminate the epigenetic regulation mechanisms in monocyte and macrophage and their contributions to inflammatory processes of atherosclerosis to provide new thoughts and find novel targets or biomarkers for atherosclerosis.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Atherosclerosis; Epigenetics; Inflammation; Macrophage; Monocyte

Mesh:

Year:  2017        PMID: 28371472     DOI: 10.1111/1755-5922.12262

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  8 in total

Review 1.  Recent insights into atherosclerotic plaque cell autophagy.

Authors:  Dan Ni; Zhongcheng Mo; Guanghui Yi
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-18

2.  Screening of biopolymeric materials for cardiovascular surgery toxicity-Evaluation of their surface relief with assessment of morphological aspects of monocyte/macrophage polarization in atherosclerosis patients.

Authors:  Natalia G Menzyanova; Svetlana А Pyatina; Elena D Nikolaeva; Alexander V Shabanov; Ivan V Nemtsev; Dmitry P Stolyarov; Dmitry B Dryganov; Eugene V Sakhnov; Ekaterina I Shishatskaya
Journal:  Toxicol Rep       Date:  2018-11-16

3.  Anti-inflammatory and atheroprotective properties of glucagon.

Authors:  Naoya Osaka; Hideki Kushima; Yusaku Mori; Tomomi Saito; Munenori Hiromura; Michishige Terasaki; Hironori Yashima; Makoto Ohara; Tomoyasu Fukui; Takanori Matsui; Tsutomu Hirano; Sho-Ichi Yamagishi
Journal:  Diab Vasc Dis Res       Date:  2020 May-Jun       Impact factor: 3.291

4.  CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206/ASPH axis in atherosclerosis cell model in vitro.

Authors:  Xiaojuan Wang; Ming Bai
Journal:  BMC Cardiovasc Disord       Date:  2021-02-02       Impact factor: 2.298

Review 5.  DNA Methylation Aberrant in Atherosclerosis.

Authors:  Yao Dai; Danian Chen; Tingting Xu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

6.  Serum level of total histone 3, H3K4me3, and H3K27ac after non-emergent cardiac surgery suggests the persistence of smoldering inflammation at 3 months in an adult population.

Authors:  Krzysztof Laudanski; Da Liu; Jihane Hajj; Danyal Ghani; Wilson Y Szeto
Journal:  Clin Epigenetics       Date:  2022-09-06       Impact factor: 7.259

Review 7.  Macrophage-Based Therapies for Atherosclerosis Management.

Authors:  Renyi Peng; Hao Ji; Libo Jin; Sue Lin; Yijiang Huang; Ke Xu; Qinsi Yang; Da Sun; Wei Wu
Journal:  J Immunol Res       Date:  2020-01-29       Impact factor: 4.818

8.  Novel and Known Gene-Smoking Interactions With cIMT Identified as Potential Drivers for Atherosclerosis Risk in West-African Populations of the AWI-Gen Study.

Authors:  Palwende Romuald Boua; Jean-Tristan Brandenburg; Ananyo Choudhury; Scott Hazelhurst; Dhriti Sengupta; Godfred Agongo; Engelbert A Nonterah; Abraham R Oduro; Halidou Tinto; Christopher G Mathew; Hermann Sorgho; Michèle Ramsay
Journal:  Front Genet       Date:  2020-02-07       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.